Komori
Other Disclosures7775DAIKEN MEDICAL CO.,LTD.Electrical Equipment and Precision Instruments

Status of approval of the MDR (Medical Device Regulation) application for the European rollout of the クーデックエイミーPCA patient-controlled analgesia pump (Progress on Previously Disclosed Matter)

The Company is preparing the clinical evaluation and post-market clinical follow-up plan (PMCF plan) and compiling the application documents to obtain MDR certification in Europe for the 「クーデックエイミーPCA」 PCA infusion pump. The MDR application is planned for the current fiscal year, but the timing of certification remains undetermined.

Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Avoiding a definitive answer
How definitive the wording is.

Announced details

CADD Amy PCA
Applicable field (uses covered by this announcement)

Medical devices, European expansion, and overseas expansion including Asia and South America

Relationship between the counterparty and the company
DAIKEN MEDICAL CO.,LTD.7775
Relationship with the Company

The Company is working with external specialists to prepare for responding to the certification body.

Award/certification name

MDR (European Medical Device Regulation) certification

Awarding / certifying body

Certification body (name not disclosed)

Impact on Business Performance

The impact of this matter on results for the current fiscal year is currently expected to be minor.

The company does not address Contract Value / Offering price.

Announced details
ItemDetails
Names of Products / Services CoveredCADD Amy PCA
Relationship with the CompanyThe Company is working with external specialists to prepare for responding to the certification body.
Applicable areaMedical devices, European expansion, and overseas expansion including Asia and South America
Award/certification nameMDR (European Medical Device Regulation) certification
Awarding / certifying bodyCertification body (name not disclosed)
Impact on Business PerformanceThe impact of this matter on results for the current fiscal year is currently expected to be minor.
Items this document does not state (12)
CounterpartyCounterparty overviewContract ValueOffering priceContract DateLaunch dateRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historySource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company is undertaking additional work for the clinical evaluation, preparing the PMCF plan and application documents, and preparing to respond to the certification body in connection with obtaining MDR certification in Europe. As the timing of certification depends on factors including the certification body's review process, it is difficult to forecast a specific timeframe.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Status of approval of the MDR (Medical Device Regulation) application for the European rollout of the クーデックエイミーPCA patient-controlled analgesia pump (Progress on Previously Disclosed Matter) | DAIKEN MEDICAL CO.,LTD. (7775) timely disclosure | Komori